781 related articles for article (PubMed ID: 20919593)
21. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
22. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
Bridges JF
Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
24. Preference-based quality of life measures in people with visual impairment.
Kymes SM; Lee BS
Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
[TBL] [Abstract][Full Text] [Related]
25. What should the government do regarding health policy-making to develop community health care in Shanghai?
Yu Y; Sun X; Zhuang Y; Dong X; Liu H; Jiang P; Yu Z; Zhang Y
Int J Health Plann Manage; 2011; 26(4):379-435. PubMed ID: 22213259
[TBL] [Abstract][Full Text] [Related]
26. Mental health service delivery following health system reform in Colombia.
Romero-González M; González G; Rosenheck RA
J Ment Health Policy Econ; 2003 Dec; 6(4):189-94. PubMed ID: 14713726
[TBL] [Abstract][Full Text] [Related]
27. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
[TBL] [Abstract][Full Text] [Related]
28. Are subjective well-being measures any better than decision utility measures?
Smith DM; Brown SL; Ubel PA
Health Econ Policy Law; 2008 Jan; 3(Pt 1):85-91. PubMed ID: 18634635
[TBL] [Abstract][Full Text] [Related]
29. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
30. Effects of antipsychotic medication on psychiatric service utilization and cost.
Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
[TBL] [Abstract][Full Text] [Related]
31. The future of outcomes measurement in rheumatology.
Kaplan RM
Am J Manag Care; 2007 Dec; 13 Suppl 9():S252-5. PubMed ID: 18095788
[TBL] [Abstract][Full Text] [Related]
32. Elicitation of informed general population health state utility values: a review of the literature.
McTaggart-Cowan H
Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
[TBL] [Abstract][Full Text] [Related]
33. Application of classic utilities to published pediatric cost-utility studies.
Finnell SM; Carroll AE; Downs SM
Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
[TBL] [Abstract][Full Text] [Related]
34. Utility measurement in healthcare: the things I never got to.
Torrance GW
Pharmacoeconomics; 2006; 24(11):1069-78. PubMed ID: 17067192
[TBL] [Abstract][Full Text] [Related]
35. Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?
Boye KS; Matza LS; Feeny DH; Johnston JA; Bowman L; Jordan JB
Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):437-50. PubMed ID: 24832003
[TBL] [Abstract][Full Text] [Related]
36. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
Ungar WJ
Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
[TBL] [Abstract][Full Text] [Related]
37. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
Brett Hauber A; Fairchild AO; Reed Johnson F
Appl Health Econ Health Policy; 2013 Aug; 11(4):319-29. PubMed ID: 23637054
[TBL] [Abstract][Full Text] [Related]
38. Translating and adapting mental health service outcome measurements for use in Taiwan.
Ching YC
J Nurs Res; 2011 Sep; 19(3):190-8. PubMed ID: 21857326
[TBL] [Abstract][Full Text] [Related]
39. Test-retest reliability of health state valuation techniques: the time trade off and person trade off.
Robinson S
Health Econ; 2011 Nov; 20(11):1379-91. PubMed ID: 21053203
[TBL] [Abstract][Full Text] [Related]
40. Preference-based measures in economic evaluation in health care.
Neumann PJ; Goldie SJ; Weinstein MC
Annu Rev Public Health; 2000; 21():587-611. PubMed ID: 10884966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
